Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Apheresis Market, by Procedure
1.4.2 Europe Apheresis Market, by Product
1.4.3 Europe Apheresis Market, by Method
1.4.4 Europe Apheresis Market, by End User
1.4.5 Europe Apheresis Market, by Component
1.4.6 Europe Apheresis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Geographical Expansions
3.2.4 Approval and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Europe Apheresis Market by Procedure
4.1 Europe Donor/Automated Market by Country
4.2 Europe Therapeutic Market by Country
Chapter 5. Europe Apheresis Market by Product
5.1 Europe Disposable & Reagents Market by Country
5.2 Europe Devices Market by Country
5.3 Europe Software Market by Country
Chapter 6. Europe Apheresis Market by Method
6.1 Europe Centrifugation Market by Country
6.2 Europe Membrane Separation Market by Country
6.3 Europe Selective Adsorption Market by Country
Chapter 7. Europe Apheresis Market by End User
7.1 Europe Blood Centers Market by Country
7.2 Europe Hospitals Market by Country
7.3 Europe Others Market by Country
Chapter 8. Europe Apheresis Market by Component
8.1 Europe Plasma (Plasmapheresis) Market by Country
8.2 Europe Platelets (Plateletpheresis) Market by Country
8.3 Europe Leukocytes (Leukapheresis or leukopheresis) Market by Country
8.4 Europe Lymphocytes (Lymphopheresis or lymphapheresis) Market by Country
8.5 Europe RBC's (Erythropheresis) Market by Country
Chapter 9. Europe Apheresis Market by Country
9.1 Germany Apheresis Market
9.1.1 Germany Apheresis Market by Procedure
9.1.2 Germany Apheresis Market by Product
9.1.3 Germany Apheresis Market by Method
9.1.4 Germany Apheresis Market by End User
9.1.5 Germany Apheresis Market by Component
9.2 UK Apheresis Market
9.2.1 UK Apheresis Market by Procedure
9.2.2 UK Apheresis Market by Product
9.2.3 UK Apheresis Market by Method
9.2.4 UK Apheresis Market by End User
9.2.5 UK Apheresis Market by Component
9.3 France Apheresis Market
9.3.1 France Apheresis Market by Procedure
9.3.2 France Apheresis Market by Product
9.3.3 France Apheresis Market by Method
9.3.4 France Apheresis Market by End User
9.3.5 France Apheresis Market by Component
9.4 Russia Apheresis Market
9.4.1 Russia Apheresis Market by Procedure
9.4.2 Russia Apheresis Market by Product
9.4.3 Russia Apheresis Market by Method
9.4.4 Russia Apheresis Market by End User
9.4.5 Russia Apheresis Market by Component
9.5 Spain Apheresis Market
9.5.1 Spain Apheresis Market by Procedure
9.5.2 Spain Apheresis Market by Product
9.5.3 Spain Apheresis Market by Method
9.5.4 Spain Apheresis Market by End User
9.5.5 Spain Apheresis Market by Component
9.6 Italy Apheresis Market
9.6.1 Italy Apheresis Market by Procedure
9.6.2 Italy Apheresis Market by Product
9.6.3 Italy Apheresis Market by Method
9.6.4 Italy Apheresis Market by End User
9.6.5 Italy Apheresis Market by Component
9.7 Rest of Europe Apheresis Market
9.7.1 Rest of Europe Apheresis Market by Procedure
9.7.2 Rest of Europe Apheresis Market by Product
9.7.3 Rest of Europe Apheresis Market by Method
9.7.4 Rest of Europe Apheresis Market by End User
9.7.5 Rest of Europe Apheresis Market by Component
Chapter 10. Company Profiles
10.1 Fresenius SE & Co. KGaA
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Acquisition and Mergers:
10.1.5.2 Geographical Expansions:
10.2 Terumo Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Partnerships, Collaborations, and Agreements:
10.2.4.2 Geographical Expansions:
10.2.4.3 Approvals and Trials:
10.3 Charles River Laboratories International, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Recent strategies and developments:
10.3.4.1 Acquisition and Mergers:
10.4 Haemonetics Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Approvals and Trials:
10.5 Asahi Kasei Medical Co., Ltd.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Acquisition and Mergers:
10.6 Kaneka Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.7 Cerus Corporation
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expense
10.8 B. Braun Melsungen AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.9 Nikkiso Co., Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental Analysis
10.9.4 Research & Development Expense
10.10. SB Kawasumi Laboratories, Inc.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
Unique Offerings 